About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Oral Cancer Screening and Education in Hong Kong | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04487938

Oral Cancer Screening and Education in Hong Kong

This study will be conducted to obtain data on oral cancer risk factors to generate machine learning models with good predictive accuracy for stratifying individuals with high-oral cancer risk and del...

Lead sponsor: The University of Hong Kong•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

John Adeoye

CONTACT

56441784 jaadeoye@hku.hk

Sponsors

Lead Sponsor

The University of Hong Kong

Age

45 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy individuals satisfying age and residential area criteria with no previous history of oral cancer. Individuals with a history of other cancers will be included in the study provided they have been in remission for more than three years.

Exclusion Criteria

•Participants with reduced mouth opening (irrespective of the cause) to permit proper administration of VOE or photosensitive epilepsy will be excluded. Likewise, those who decline the provision of written consent or participation in any part of the study.

Related studies

Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model

NCT06629038 · Oral Cancer

Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment

NCT07331935 · Oral Leukoplakia

RECRUITINGPhase 2

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

NCT05727761 · Oral Leukoplakia

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

NCT07203911 · Tongue Cancer, Oral Cancer, and more

EVALUATION OF SALIVA AS LIQUID BIOPSY FOR EARLY DETECTION OF ORAL CANCER IN PATIENTS WITH ORAL-SUBMUCOUS FIBROSIS (OSMF)

NCT07122128 · The Study Focuses on the Saliva as Potential Source of Early Detection of Oral Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 27, 2020Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment3,190

Start dateAug 2021

Last updatedJul 27, 2020

Condition

Oral Cancer Oral Leukoplakia Oral Submucous Fibrosis Proliferative Verrucous Leukoplakia Oral Erythroplakia+1 more

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 27, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions